5 ML fulvestrant 50 MG/ML Prefilled Syringe [Faslodex]
- RxCUI
- 727954
- RxNorm name
- 5 ML fulvestrant 50 MG/ML Prefilled Syringe [Faslodex]
- Display name
- 5 ML fulvestrant 50 MG/ML Prefilled Syringe [Faslodex]
- Full name
- 5 ML fulvestrant 50 MG/ML Prefilled Syringe [Faslodex]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:06
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FASLODEX | FULVESTRANT | AstraZeneca Pharmaceuticals LP | 83d7a440-e904-4e36-afb5-cb02b1c919f7 | 2020-09-25 | Warnings, Adverse reactions | 727954 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 83d7a440-e904-4e36-afb5-cb02b1c919f7 | FASLODEX 250 MG in 5 ML Prefilled Syringe [PSN] · 5 ML fulvestrant 50 MG/ML Prefilled Syringe [Faslodex] [SBD] · 5 ML Faslodex 50 MG/ML Prefilled Syringe [SY] · Faslodex 250 MG per 5 ML Prefilled Syringe [SY] | 4 | 43 | These highlights do not include all the information needed to use FASLODEX safely and effectively. See full prescribing information for FASLODEX. FASLODEX ® (fulvestrant) injection, for intramuscular use Initial U.S. Approval: 2002 | 20200925 |